| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/07/2002 | CA2417550A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 02/07/2002 | CA2417454A1 Peptide-mediated delivery of molecules into cells |
| 02/07/2002 | CA2417364A1 Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses |
| 02/07/2002 | CA2417359A1 Protein phosphatases |
| 02/07/2002 | CA2417349A1 Novel proteins and nucleic acids encoding same |
| 02/07/2002 | CA2417344A1 Methods for enhancing targeted gene alteration using oligonucleotides |
| 02/07/2002 | CA2417195A1 G-protein coupled receptors |
| 02/07/2002 | CA2417100A1 Modified peptides with increased potency |
| 02/07/2002 | CA2417087A1 Mammalian dna binding membrane-associated protein-encoding gene and uses |
| 02/07/2002 | CA2416893A1 Modified cea and uses thereof |
| 02/07/2002 | CA2416877A1 Somatic cloning gene transfer for producing recombinant proteins, cells and organs |
| 02/07/2002 | CA2416820A1 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 02/07/2002 | CA2416800A1 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 02/07/2002 | CA2416788A1 Methods and pharmaceutical compositions comprising protein kinase c isoforms for healing wounds |
| 02/07/2002 | CA2416732A1 Endothelial cell expression patterns |
| 02/07/2002 | CA2416260A1 Promyostatin peptides and methods of using same |
| 02/07/2002 | CA2416156A1 Accessory cholera enterotoxin and analogs thereof as activators of calcium dependent chloride channel |
| 02/07/2002 | CA2415473A1 Apo-2l receptor agonist and cpt-11 synergism |
| 02/07/2002 | CA2415436A1 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 02/07/2002 | CA2415433A1 A human disintegrin protein |
| 02/07/2002 | CA2405728A1 Lipid-peptide conjugates for treatment of cancer |
| 02/07/2002 | CA2388550A1 Dispersions for formulating slightly or poorly soluble active ingredients |
| 02/07/2002 | CA2385910A1 Somatostatin analogs for the treatment of cancer |
| 02/06/2002 | EP1178116A1 Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof |
| 02/06/2002 | EP1178115A2 Phosphodiesterase |
| 02/06/2002 | EP1178053A2 Polypeptides and polynucleotides coding therefor from a family of G-protein coupled receptors and their use for the diagnosis and treatment of skin diseases |
| 02/06/2002 | EP1177785A2 Growth promoting pharmaceutical implant |
| 02/06/2002 | EP1177312A2 Human gil-19/ae289 proteins and polynucleotides encoding same |
| 02/06/2002 | EP1177304A2 Modified vitamin k-dependent polypeptides |
| 02/06/2002 | EP1177298A1 Autotaxin variants and uses to treat diseases of metabolism |
| 02/06/2002 | EP1177297A2 Novel nucleic acids and proteins with growth hormone activity |
| 02/06/2002 | EP1177296A2 Extracellular matrix and adhesion-associated proteins |
| 02/06/2002 | EP1177295A1 Ox2 receptor homologs |
| 02/06/2002 | EP1177293A1 Growth factor homolog zvegf4 |
| 02/06/2002 | EP1177292A2 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 02/06/2002 | EP1177291A2 Laminin 8 and methods for its use |
| 02/06/2002 | EP1177290A2 Recombinant laminin 5 |
| 02/06/2002 | EP1177289A1 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 02/06/2002 | EP1177287A2 Secreted human proteins |
| 02/06/2002 | EP1177286A1 Mdm interacting protein and methods of use thereof |
| 02/06/2002 | EP1177285A1 Chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
| 02/06/2002 | EP1177212A1 Lawsonia derived gene and related sodc polypeptides, peptides and proteins and their uses |
| 02/06/2002 | EP1177210A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus |
| 02/06/2002 | EP1177208A1 Spray drying of thrombin inhibitors |
| 02/06/2002 | EP1177207A1 Dna encoding the prostate-specific membrane antigen-like gene and uses thereof |
| 02/06/2002 | EP1177197A2 Polyamines and their use in therapy |
| 02/06/2002 | EP1177168A1 Caspase inhibitors and the use thereof |
| 02/06/2002 | EP1176980A1 Ccr4 antagonists in sepsis |
| 02/06/2002 | EP1176977A2 Ceruloplasmin and an antioxidant composition comprising the same and their uses as neuroprotective agent |
| 02/06/2002 | EP1176976A1 Gonadotrophins |
| 02/06/2002 | EP1176975A1 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 02/06/2002 | EP1176969A2 Substitution infusion fluid and citrate anticoagulation |
| 02/06/2002 | EP1176968A2 Selenium-containing pro-drugs for cancer therapy |
| 02/06/2002 | EP1176965A1 Antisense modulation of fas mediated signaling |
| 02/06/2002 | EP1176957A1 Method for treating abnormal cell proliferation in the brain |
| 02/06/2002 | EP1176949A2 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same |
| 02/06/2002 | EP1176871A1 Novel beta-secretase and modulation of beta-secretase activity |
| 02/06/2002 | EP1176870A2 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 02/06/2002 | EP1162990A4 Treatment with small peptides to effect antifibrotic activity |
| 02/06/2002 | EP1067946A4 Anti-bacterial protein extracts from seeds of marigold and paprika |
| 02/06/2002 | EP1021200B1 Methods and compositions for treating rheumatoid arthritis |
| 02/06/2002 | EP0938330B1 Use of lh-rh antagonists as diagnostic agent |
| 02/06/2002 | EP0906020B1 Use of a fungal composition for crop protection |
| 02/06/2002 | EP0885392B1 Process for differential diagnosis of various states of alzheimer's disease |
| 02/06/2002 | EP0882024B1 Retroviral protease inhibiting compounds |
| 02/06/2002 | EP0866865B1 Chimeric oligomers having an rna-cleavage activity |
| 02/06/2002 | EP0835305A4 Cytokine that induces apoptosis |
| 02/06/2002 | EP0832105A4 Immunogenic peptides of prostate specific antigen |
| 02/06/2002 | EP0777487B1 Treatment of stroke associated with macrophage infiltration |
| 02/06/2002 | EP0774973B1 Treatment of cancer with human chorionic gonadotropin |
| 02/06/2002 | EP0764028B1 Method of treating retained pulmonary secretions |
| 02/06/2002 | EP0762888B1 Copolymer-1 improvements in compositions of copolymers |
| 02/06/2002 | EP0730448B1 Use of nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor for the manufacture of medicaments for the treatment of uterine contractility disorders |
| 02/06/2002 | EP0716611B1 C1-esterase inhibitor to reduce myocardial injury during acute myocardial infarction |
| 02/06/2002 | EP0712936B1 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it |
| 02/06/2002 | EP0670896B1 Cloning and expression of biologically active alpha-galactosidase a |
| 02/06/2002 | EP0659082B1 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine |
| 02/06/2002 | EP0547163B1 Protein polyligands joined to a stable protein core |
| 02/06/2002 | CN1334875A Cell signalling polypeptides and nucleic acids |
| 02/06/2002 | CN1334873A Tumor Antigen protein ART-1 and tumor antigen peptide thereof |
| 02/06/2002 | CN1334820A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334819A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334743A Method for accelerating rate of mucociliary clearance |
| 02/06/2002 | CN1334742A Method of using lanreotide as somatostatin analogue |
| 02/06/2002 | CN1334741A 肽的用途 Use of a peptide |
| 02/06/2002 | CN1334702A Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 02/06/2002 | CN1334271A Renaturation process for preparing human recombinant nerve growth factor |
| 02/06/2002 | CN1334122A Medicine for treating HIV infection, its composition and its use |
| 02/06/2002 | CN1078886C Inhibitor of inhibiting generation of beta-amyloid |
| 02/05/2002 | US6344600 Method for producing human hemoglobin proteins using plant cells |
| 02/05/2002 | US6344596 Expression of active human factor IX in mammary tissue and of milk non human transgenic mammals |
| 02/05/2002 | US6344562 Thiazole derivatives |
| 02/05/2002 | US6344552 Compositions and methods comprising DNA sequences encoding B. burgdorferi polypeptides |
| 02/05/2002 | US6344551 Contulakin-G, analogs thereof and uses therefor |
| 02/05/2002 | US6344550 A dna molecule; diagnosing, monitoring and therapy of breast cancer |
| 02/05/2002 | US6344548 Diacylglycerol o-acyltransferase |
| 02/05/2002 | US6344547 Human MutT2 |
| 02/05/2002 | US6344546 A receptor protein with a cytoplasmic domain having protein kinase activity, a kinase insert, a transmembrane domain and an extracellular domain having three immunoglobulin-like repeats; for drug screening |
| 02/05/2002 | US6344544 Semaphorin-specific antibodies |
| 02/05/2002 | US6344543 Human transcription factor IIA |